Published on 5 December 2023
Description:
Full coverage of the 23rd annual PMEAs; Virtual patient care – a glimpses of an exciting future; Rare diseases – the importance of screening for SMA
Categories:
Pharmaceutical Market EuropePreview:
31 articles from this collection:
PME December 2023
2 - COMMUNIQUÉ 2024
3 - Comment
4 - PME
5 - Contents
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8-9 - News
10-11 - Dermatology News
12 - DARWIN'S MEDICINE - T is for Trouble
12 - Pharma Market Europe Darwin’s medicine
13 - POLICY AND PUBLIC HEALTH - A time of reflection
14 - MIKE DIXON - Living in a VUCA world
15 - INNOVATIVE IMPACT BLOG - Building the pharmaceutical team of tomorrow
16-17 - GENETIC TESTING
18 - TL AKT HEALTH - The vital role of cultural competency in women’s health communications
19 - TL HCG - Reimagining scientific publications
20-21 - CELL AND GENE THERAPIES
22 - TL STEM - Preventing strategic drift: aligning teams for a successful pharma product launch
23 - TL SAY - What does the changing social media landscape mean for pharma?
24-25 - RARE DISEASES - UK at an inflection point for newborn screening for spinal muscular atrophy
26 - TL MADANO - Quality not quantity
27 - TL MAKARA - Harnessing the power of PR to boost marketing communications
28-33 - PMEA AWARDS 2023
34-35 - PATIENT CARE - Virtual care
36 - TL HEALTH UNLIMITED - Integrating shared decision-making in patient engagement plans
37-39 - BUSINESS CAPABILITIES
40-41 - OMNICHANNEL - Transforming HCP interactions with a robust omnichannel approach
42-44 - Appointments
45 - HEALTHCARE COMMS
46 - RECRUITMENT
47 - PHARMAROLE
48 - SAMEDAN LTD
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services